Armin Helisch
Overview
Explore the profile of Armin Helisch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fung E, Helisch A
Front Physiol
. 2012 Oct;
3:353.
PMID: 23055975
Arteriosclerotic vascular disease is the most common cause of death and a major cause of disability in the developed world. Adverse outcomes of arteriosclerotic vascular disease are related to consequences...
2.
Zlotnick D, Helisch A
Ann Intern Med
. 2012 Jan;
156(2):171-2.
PMID: 22250160
No abstract available.
3.
Rajashekhar G, Willuweit A, Patterson C, Sun P, Hilbig A, Breier G, et al.
J Vasc Res
. 2006 Jan;
43(2):193-204.
PMID: 16410682
There is increasing evidence that chronic inflammation is tightly linked to diseases associated with endothelial dysfunction, including the induction of aberrant angiogenesis. While leukocytes have been described as mediators of...
4.
Helisch A, Wagner S, Khan N, Drinane M, Wolfram S, Heil M, et al.
Arterioscler Thromb Vasc Biol
. 2006 Jan;
26(3):520-6.
PMID: 16397137
Objective: To assess the importance of genetic background for collateral artery development. Methods And Results: C57BL/6, BALB/c and 129S2/Sv mice were studied after femoral artery ligation by laser Doppler imaging,...
5.
Tirziu D, Moodie K, Zhuang Z, Singer K, Helisch A, Dunn J, et al.
Circulation
. 2005 Oct;
112(16):2501-9.
PMID: 16230502
Background: Hypercholesterolemia has been reported to inhibit ischemia-induced angiogenesis. To address its effects on arteriogenesis, we investigated arterial growth in hypercholesterolemic low-density lipoprotein receptor(-/-)/ApoB-48(-/-) (HCE) mice. Methods And Results: The...
6.
Girardin E, HajMohammadi S, Birmele B, Helisch A, Shworak N, de Agostini A
J Biol Chem
. 2005 Aug;
280(45):38059-70.
PMID: 16107334
Endothelial and other select cell types synthesize a subpopulation of heparan sulfate (HS) proteoglycans (HSPGs), anticoagulant HSPGs (aHSPGs) that bear aHS-HS chains with the cognate 3-O-sulfated pentasaccharide motif that can...
7.
Wagner S, Helisch A, Bachmann G, Schaper W
J Magn Reson Imaging
. 2004 Apr;
19(4):468-74.
PMID: 15065171
Purpose: To evaluate the feasibility of using time-of-flight (TOF) imaging to directly measure hindlimb blood flow in a mouse model of peripheral vascular disease. Materials And Methods: Four tubes were...
8.
Wagner S, Helisch A, Ziegelhoeffer T, Bachmann G, Schaper W
NMR Biomed
. 2004 Mar;
17(1):21-7.
PMID: 15011247
The in vivo detection of growing collateral vessels following arterial occlusion is difficult in small animals. We have addressed the feasibility of performing high resolution time-of-flight angiograms to monitor the...
9.
Ashton A, Cheng Y, Helisch A, Ware J
Circ Res
. 2004 Feb;
94(6):735-42.
PMID: 14963009
Thromboxane (TX) A2 is released from multiple cell types and is a prime mediator of the pathogenesis of many vascular events, including angiogenesis. Endothelial cells express TXA2 receptors (TP) but...
10.
Heil M, Ziegelhoeffer T, Wagner S, Fernandez B, Helisch A, Martin S, et al.
Circ Res
. 2004 Feb;
94(5):671-7.
PMID: 14963007
Arteriogenesis has been associated with the presence of monocytes/macrophages within the collateral vessel wall. Induced macrophage migration in vivo is driven by the binding of monocyte chemoattractant protein-1 (MCP-1, or...